Biotech company Acuitas Therapeutics and Germany-based CureVac have settled Acuitas' lawsuit demanding credit for inventions ...
Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants ...
CureVac and Acuitas Therapeutics have settled their COVID-19 vaccine dispute. According to a filing, submitted April 25, 2024 ...
In 2022, CureVac sued rival BioNTech for patent infringement, claiming some of that company’s success in COVID-19 was based on CureVac’s intellectual property. Litigation between the two ...
GSK said in the lawsuit , opens new tab that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the ...
CureVac is asserting its intellectual property rights in litigation against Pfizer/BioNTech in Germany, the U.S. and the UK. In the U.S., a magistrate judge recently granted a motion by Acuitas ...
BioNtech-Pfizer has promised to deliver up to 75 million more coronavirus vaccine doses to the EU in the second quarter of 2021, the company's head Sierk Poetting said in a statement on Monday. So ...
Six inmates at a New York state prison will be allowed to watch next week's solar eclipse after they sued the corrections department following its decision to lock down facilities during the rare ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Benzinga - by Vandana Singh, Benzinga Editor. Canadian Biotech company Acuitas Therapeutics and Germany-based CureVac NV (NASDAQ:CVAC) have settled Acuitas’ lawsuit over credit for inventions tied to ...
CureVac is asserting its intellectual property rights in litigation against Pfizer/BioNTech in Germany, the U.S. and the UK. In the U.S., a magistrate judge recently granted a motion by Acuitas ...